INDV

#1245
Indivior Pharmaceuticals, Inc. Common Stock
32.7200
-0.52%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
32.7200
32.7200
Jahresspanne
32.4900
36.0300
Tagesänderung
-0.52%
Monatliche Änderung
-5.62%
6 month change
-2.62%
Jahresänderung
-2.62%
Vorheriger Schlusskurs
32.8900
Open
32.7200
Bid
Ask
Low
32.7200
High
32.7200
Volumen
148
Open full chart

Financials

Overview Finanzbericht Statistics Dividends
Quarterly Annual
  • Market Capitalization 4.09 B
  • Employee 1 051
  • Founded 2014
  • CEO Mark Crossley
  • Website www.indivior.com
  • Headquarter Delaware, United States
  • FIGI BBG01ZTXFLQ6
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
21.88
Price to sales ratio
—
Dividends per share
—
Dividend yield %
—

Indivior Pharmaceuticals Inc

Indivior is an American pharmaceuticals company. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, it is focussed on substitution products for opioid addiction. It is listed on the London Stock Exchange and on the NASDAQ Global Select Market.

Nachrichten